|
 |
European BioPharmaceutical Review
|
| Over the decades, billions of dollars have gone into the war against cancer. Nonetheless, in 2003 an estimated 556,500 people will die from the disease in the US - about five per cent more than the mortality rate recorded in 1950. In recent months however, the US Food and Drug Administration approved several innovative biotech drugs that are designed to attack the disease in new ways and hundreds of additional compounds are in various stages of clinical trials. Could it be that we are gaining on cancer at last? |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Clinical Trials in CNS
25-26 November 2008, Copthorne Tara Hotel, London, UK
SMi present their 7th annual conference… Clinical Trials in CNS 25th to 26th November 2008, Copthorne Tara Hotel, London, UK
More info >> |
|
 |
News and Press Releases |
 |
Financial Times hosts the Global Pharmaceutical and Biotechnology Conference
13th November 2008
More info >> |
|
 |
